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ABSTRACT 
The purpose of this paper is to perform dosimetric verification (in-phantom) of dose distributions calculated with treatment 
planning system (TPS) by using  2D chamber array device in HDR brachytherapy. HDR brachytherapy treatment 
plans’dose distribution verification is performed using the two-dimensional (2D) ionization chamber array MatriXX 
Evolution developed by IBA Dosimetry (IBA Dosimetry, Germany) whose detector area is covered with the Nucletron 
Freiburg Flap Applicator Set (Nucletron BV,Veenendaal, the Netherlands) with catheters such that the detector plane was 
set to 0.86 cm from the catheter plane. Fixed slabs of RW3 (Perspex) were added below the 2D-ARRAY to provide full 
scattering conditions. The phantom was scanned on computed tomography (CT) for treatment planning with 2.5-mm slice 
thickness. Based on the CT data of the phantom, three different plans were calculated by the planning system 
(Oncentrabrachy version 4.3, Nucletron BV) and then are exported to the VERISOFT software for comparison with 
measured data. For comparison of dose distributions, both dose planes – measured & calculated – were normalized  to 
the global maximum dose of the reference matrix (measured data set) and compared using the Gamma index method. 
Gamma indexes were evaluated using a dose-difference criterion of 3% and a distance criterion of 3 mm (γ≤1).The total 
number of evaluated dose points for the vault test case  is 9755, 98.6 % of them (9623 point) passed the criteria of 
acceptability (3% delta dose and 3-mm distance criteria) and 1.4% of them (132 point) failed it. The total number of 
evaluated dose points for the full test case is 19964, 93.6 % of them (18683 point) passed  the criteria of acceptability and 
6.4% of them (1281 point) failed it. And the total number of evaluated dose points for the cylinder test case is 19871, 96.9 
% of them (19258 point) passed the criteria of acceptability and 3.1% of them (613 point) failed it. By thisThe use of the 
two-dimensional (2D) ionization chamber array MatriXX Evolution for brachytherapy applications has been successfully 
demonstrated. The array measurements in these planes have shown acceptable agreement with the TPS, generally within 
3% delta dose and 3-mm distance agreement criteria within each plane. The comparisons made led to make a relation 
between the passing percentage values to the number of the evaluated dose points for each test case and it was found 
that as the number of these pixels increases the possibility of having more failing points increases. 
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INTRODUCTION  
 The efficacy of radiation therapy relies on the accuracy of dose delivery to patients. Proper implementation of a 
treatment planning system for accurate treatment dose calculations and quality assurance procedures to detect dosimetric 
errors are of critical importance. Since the Brachytherapy treatment planning systems use simplified algorithmsin their 
dose calculations, verification of the dose distributions presented by the systems may be of clinical importance. Evaluation 
of the treatment planning systems in terms of their presented dose distribution can be a part of quality assurance in the 
clinical practice of brachytherapy.The dose distribution generated by the TPS using the AAPM TG-43 dose formalism [1]  
is usually compared with the calculations using the Sievert summation [2], Monte Carlo simulation [3], or dose distributions 
measured with Gafchromic film [4].  Gafchromic film is an excellent tool for dosimetry but involves a consumable cost, 
requires characterization of both the filmand the scanner, and presents several technical challenges in yielding accurate 
dosimetric results [5]. Recently, 2D ionization chamber arrays have become increasingly popular for intensity-modulated 
radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) plan verification. The detector was found to be 
linear with dose, independent of dose rate,and a suitable device for quality assurance and 2D dose verifications of 
megavoltage beams. 
MATERIALS AND METHOD 
In this study, Nucletron (Nucletron, Veenendaal, The Netherlands) MicroSelectron remote-afterloading HDR 
brachytherapy 30 channels unit (for treatment applicator connection) fed with Nucletron Ir-192 HDR-v2r (new design) 
radiation source is used to deliver the  prescribed radiation dose planned by Oncentra-Master-Plan-Brachy treatment 
planning system whose calculation algorithm is based on AAPM TG-43 dose formalism. The dosimetric verification is 
performed using the two-dimensional (2D) ionization chamber array MatriXX Evolution developed by IBA Dosimetry (IBA 
Dosimetry, Germany). The MatriXX Evolution consists of 1020 vented, plane-parallel cylindrical ionization chambers 
arranged in a 32 x 32 matrix with a maximum field-of-view of 24.4 x 24.4 cm
2
. The chamber size is 4.5-mm diameter and 
5-mm height, center-to-centerdistance is 0.76 cm, active volume is 0.08 cm
3
 [6, 7]. The detector area is covered with the 
Nucletron Freiburg Flap Applicator Set (Nucletron BV,Veenendaal, the Netherlands)with catheters such that the detector 
plane was set to 0.86 cm from the catheter plane [8]. The Freiburg Flap Applicator Set shown in figurer 1  is a flexible 
mesh style surface mold made of silicone rubber with 36 channels for implant tubeswith a separation of 10 mm and a 
channel length of 24 cm. 
 
 
Fig 1: The Freiburg Flap Applicator Set 
The Freiburg Flap Applicator is used in conjunction with the OncoSmart flexible implant tubes which are used to guide the 
source to the points of planned implant.Fixed slabs of RW3 (Perspex) - Slabs made of Water-equivalent material 
(Goettingen White Water) - were added below and above the 2D-array to provide full scattering conditions.The phantom 
was scanned on computed tomography (CT) for the treatment planning -figure 2- with 2.5-mm slice thickness and the 
scanned images are exported to the Oncentra Master Brachy treatment planning system for performing different test 
plans.  
 
ISSN 2277-3061                                                           
6620 | P a g e                                                       J a n u a r y  2 3 ,  2 0 1 6  
 
Fig 2:  Computed tomography scanned axial image of the measurement phantom 
Based on the CT data of the phantom, three different plans imitating three different intracavitary brachytherapy treatment 
applications were calculated by the planning system.The first plan consists of two active channels to imitate the Fletcher 
GYN applicator set for vault application -figure 3- and planned to deliver 2 Gy at 1 cm (point A) lateral to the central axis 
mid the two transfer tubes.The second plan consists of three active channels to imitate the Fletcher GYN applicator set for 
full application -figure 4- and planned to deliver 2 Gy at 2 cm (point A) lateral to the tandem-like transfer tube central axis 
and at 4 cm lateral to that axis at the top level of the two other transfer tubes. The third plan consists of only one active 
channel to imitate the Fletcher GYN applicator set for cylinder application -figure 5- and planned to deliver 2 Gy at 2 cm 
(point A) lateral to the central axis of the cylinder-like transfer tube.  
 
Fig 3: Oncentra master plan brachy short-cut of the vault test case 
 
Fig 4:  Oncentra master plan brachy short-cut of the full test case 
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Fig 5:  Oncentra master plan brachy short-cut of the cylinder test case 
The treatment plans were then exported to theconsole of the MicroSelectron HDR afterloader (version 3, Nucletron BV) 
which contains the Ir-192 sourcefor practical application on the measurement phantom. The ion chamber array was 
irradiated, setting the position of the detector plane of measurement to correspond with the computed plan. The TPS 
generated plans were also exported to the VeriSoft software for comparison with measured data. For comparison of dose 
distributions, both dose planes were normalized to the global maximum dose of the reference matrix (measured data set). 
The calculated and measured dose distributions were then compared using the Gamma index method [9] where both 
plans were normalized  to the maximum dose ofthe reference matrix (measured data set), this normalization decreases 
the possibility of miss matching between measured and calculated values hence gamma passing rate results increase. 
Gamma indexes were evaluated using a dose-difference criterion of 3% and a distance criterion of 3 mm (γ≤1). 
RESULTS 
 
Figures 6-11 show comparisons of measured and TPS-calculated dose distributions for the three test patterns. 
Comparisons of dose distributions were  done using Gamma 2D global method  [9] where the passing criterion is γ≤1 (with 
3% delta dose and 3-mm distance criteria).Tables 1-3 illustrate the comparison points’ statistics for the three test 
applications. Such that the total number of evaluated dose points for the vault test case (table 1) is 9755,  98.6 % of them 
(9623 point) passed  the criteria of acceptability (3% delta dose and 3-mm distance criteria) and 1.4% of them (132 point) 
failed it.The total number of evaluated dose points for the full test case (table 2) is 19964,93.6 % of them (18683 point) 
passed the criteria of acceptability and 6.4% of them (1281point) failed it.And the total number of evaluated dose points for 
the cylinder test case (table 3) is 19871,96.9 % of them (19258 point) passed the criteria of acceptability and  3.1% of 
them (613 point) failed it. 
1- vault test case: 
 
                                               (a)                                                                        (b) 
Fig 6: (a) Dose distribution for measured plan, (b) for calculated plan 
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                                               (a)                                                                        (b) 
Fig 7: (a) Isodose comparison between the measured and calculated plans. (b) Gamma distribution of the 
comparison for the vault test case 
 
2- Full test case: 
 
(a)                                                                         (b) 
Fig 8: (a) Dose distribution for measured plan, (b) for calculated plan 
 
                                            (a)                                                                              (b) 
Fig 9: (a) Isodose comparison between the measured and calculated plans. (b) Gamma distribution of the 
comparison for the full test case 
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3- cylinder test case: 
 
 
(a)                                                                            (b) 
Fig 10: (a) Dose distribution for measured plan, (b) for calculated plan 
 
 
(a)                                                                               (b) 
 
Fig 11: (a) Isodose comparison between the measured and calculated plans. (b) Gamma distribution of the 
comparison for the cylinder test case  
                        Table 1.  The comparison points’ statistics for the vault test application 
Statistics 
 Number % 
Evaluated dose points 9755 100 
Passed 9623 98.6 
Failed 132 1.4 
                        
Table 2.  The comparison points’ statistics for the full test application 
Statistics 
 Number % 
Evaluated dose points 19964 100 
Passed 18683 93.6 
Failed 1281 6.4 
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                  Table 3.  the comparison points’ statistics for the cylinder test application 
Statistics 
 Number % 
Evaluated dose points 19871 100 
Passed 19258 96.9 
Failed 613 3.1 
 
 
Fig 12:  A chart presentation relating the number of evaluated dose points with the passed percentage 
 
Fig 13:   A chart presentation relating the number of evaluated dose points with the failed percentage 
DISCUSSION 
Comparisons were made with 3% delta dose and 3-mm distance criteriawithin the VeriSoftsoftware&both dose planes 
(measured and calculated) were normalized to the global maximum dose of the reference matrix (measured data set).The 
percentage of the number of points passedthe dose distribution comparisonin the vault test case was98.6%, in the full test 
case was 93.6% and in the cylinder test case was 96.9%. Relating these passing percentage values to the number of the 
evaluated dose points for each test case (figures 12 & 13); it can be found that as the number of these pixels increases 
the possibility of having more failing points increases. 
More likely to be illustrated in the full test case whose the maximum number of dose points (19964) and the highest failing 
percentage (6.4%) of its total evaluated dose points, and in the vault test case whose the minimum number of dose points 
(9755) and the lowest failing percentage (1.4%) of its total evaluated dose points.The relation between the passing 
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percentage of the comparison and the number of the total evaluated dose points can be interpreted to the comparison  
matrix area which when  is increased (increased number of pixels evaluated) the possibility to have more failing points is 
increased and vies versa for smaller areas. 
CONCLUSION 
The array measurement technique has been successfully validated for three different test cases (vault, full and cylinder-
like applications) against TPS dose distribution calculations. The 2D chamber array can be applied as a routine quality 
control toolproviding reliableverification toolof the actual dose distribution delivered by HDRtreatment equipment for the 
different test cases. The comparisons made led to make a relation between the passing percentage values to the number 
of the evaluated dose points for each test case and it was found that as the number of these pixels increases the 
possibility of having more failing points increases. 
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